SG194825A1 - Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells - Google Patents

Info

Publication number

SG194825A1

SG194825A1 SG2013082391A SG2013082391A SG194825A1 SG 194825 A1 SG194825 A1 SG 194825A1 SG 2013082391 A SG2013082391 A SG 2013082391A SG 2013082391 A SG2013082391 A SG 2013082391A SG 194825 A1 SG194825 A1 SG 194825A1

Authority

SG

Singapore

Prior art keywords

cells

cell

umbilical cord

cord tissue

tissue

Prior art date

2011-05-19

Links

• Espacenet
• Global Dossier
• Discuss

• 210000003954 umbilical cord Anatomy 0.000 title claims abstract description 171
• 241000282414 Homo sapiens Species 0.000 title claims abstract description 99
• 206010061246 Intervertebral disc degeneration Diseases 0.000 title claims description 14
• 208000018180 degenerative disc disease Diseases 0.000 title claims description 11
• 208000021600 intervertebral disc degenerative disease Diseases 0.000 title claims description 11
• 238000011282 treatment Methods 0.000 title description 56
• 238000000034 method Methods 0.000 claims abstract description 99
• 239000000017 hydrogel Substances 0.000 claims abstract description 55
• 201000010099 disease Diseases 0.000 claims abstract description 43
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 43
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
• 210000004027 cell Anatomy 0.000 claims description 713
• 210000001519 tissue Anatomy 0.000 claims description 212
• 108090000623 proteins and genes Proteins 0.000 claims description 105
• 230000014509 gene expression Effects 0.000 claims description 77
• 102000004169 proteins and genes Human genes 0.000 claims description 34
• 230000001228 trophic effect Effects 0.000 claims description 33
• 102000004890 Interleukin-8 Human genes 0.000 claims description 31
• 108090001007 Interleukin-8 Proteins 0.000 claims description 31
• 210000002950 fibroblast Anatomy 0.000 claims description 31
• 238000002347 injection Methods 0.000 claims description 31
• 239000007924 injection Substances 0.000 claims description 31
• 239000003795 chemical substances by application Substances 0.000 claims description 29
• 229940096397 interleukin-8 Drugs 0.000 claims description 28
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims description 28
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 26
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 26
• 108010058597 HLA-DR Antigens Proteins 0.000 claims description 24
• 102000006354 HLA-DR Antigens Human genes 0.000 claims description 24
• 108010017842 Telomerase Proteins 0.000 claims description 21
• 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 21
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 20
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 20
• 101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 claims description 17
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims description 17
• 210000004369 blood Anatomy 0.000 claims description 16
• 239000008280 blood Substances 0.000 claims description 16
• 238000000338 in vitro Methods 0.000 claims description 16
• 239000003446 ligand Substances 0.000 claims description 16
• 102100022749 Aminopeptidase N Human genes 0.000 claims description 14
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims description 14
• 102100022464 5'-nucleotidase Human genes 0.000 claims description 13
• 102100032912 CD44 antigen Human genes 0.000 claims description 13
• 102100035379 Growth/differentiation factor 5 Human genes 0.000 claims description 13
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 13
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 13
• 102000003729 Neprilysin Human genes 0.000 claims description 13
• 108090000028 Neprilysin Proteins 0.000 claims description 13
• 108010090254 Growth Differentiation Factor 5 Proteins 0.000 claims description 12
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims description 12
• 210000002798 bone marrow cell Anatomy 0.000 claims description 12
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 12
• 108010081589 Becaplermin Proteins 0.000 claims description 11
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 11
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 11
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 10
• 102100022647 Reticulon-1 Human genes 0.000 claims description 10
• 101710122684 Reticulon-1 Proteins 0.000 claims description 10
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 10
• 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 9
• 102000009410 Chemokine receptor Human genes 0.000 claims description 8
• 108050000299 Chemokine receptor Proteins 0.000 claims description 8
• 230000001939 inductive effect Effects 0.000 claims description 8
• 108010049003 Fibrinogen Proteins 0.000 claims description 7
• 102000008946 Fibrinogen Human genes 0.000 claims description 7
• 230000003399 chemotactic effect Effects 0.000 claims description 7
• 229940012952 fibrinogen Drugs 0.000 claims description 7
• 210000003714 granulocyte Anatomy 0.000 claims description 7
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims description 4
• 108090000190 Thrombin Proteins 0.000 claims description 4
• 229960004072 thrombin Drugs 0.000 claims description 4
• 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 claims 2
• 230000007850 degeneration Effects 0.000 abstract description 51
• 230000008439 repair process Effects 0.000 abstract description 14
• 230000008929 regeneration Effects 0.000 abstract description 11
• 238000011069 regeneration method Methods 0.000 abstract description 11
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 48
• 239000002953 phosphate buffered saline Substances 0.000 description 46
• 238000002595 magnetic resonance imaging Methods 0.000 description 42
• 210000004940 nucleus Anatomy 0.000 description 39
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 38
• 239000001963 growth medium Substances 0.000 description 37
• 230000012010 growth Effects 0.000 description 31
• -1 reticulon Proteins 0.000 description 31
• 235000018102 proteins Nutrition 0.000 description 30
• 241000283973 Oryctolagus cuniculus Species 0.000 description 29
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 26
• 239000000203 mixture Substances 0.000 description 25
• 239000012091 fetal bovine serum Substances 0.000 description 24
• 239000000463 material Substances 0.000 description 24
• 238000003752 polymerase chain reaction Methods 0.000 description 24
• 239000000047 product Substances 0.000 description 23
• 210000000130 stem cell Anatomy 0.000 description 22
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 22
• 230000000694 effects Effects 0.000 description 20
• 229960004857 mitomycin Drugs 0.000 description 20
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 20
• 238000000684 flow cytometry Methods 0.000 description 18
• 239000011159 matrix material Substances 0.000 description 18
• 239000002609 medium Substances 0.000 description 18
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 17
• 239000002299 complementary DNA Substances 0.000 description 17
• 210000002744 extracellular matrix Anatomy 0.000 description 17
• 238000001727 in vivo Methods 0.000 description 17
• 108010014423 Chemokine CXCL6 Proteins 0.000 description 16
• 238000004458 analytical method Methods 0.000 description 16
• 239000000872 buffer Substances 0.000 description 16
• 238000001356 surgical procedure Methods 0.000 description 15
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 15
• 230000007423 decrease Effects 0.000 description 14
• 239000003814 drug Substances 0.000 description 14
• 238000004519 manufacturing process Methods 0.000 description 14
• 229910052760 oxygen Inorganic materials 0.000 description 14
• 230000035755 proliferation Effects 0.000 description 14
• 239000000243 solution Substances 0.000 description 14
• 230000000638 stimulation Effects 0.000 description 14
• 239000006228 supernatant Substances 0.000 description 14
• 102000008186 Collagen Human genes 0.000 description 13
• 108010035532 Collagen Proteins 0.000 description 13
• 108010010803 Gelatin Proteins 0.000 description 13
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 13
• 229920001436 collagen Polymers 0.000 description 13
• 239000008273 gelatin Substances 0.000 description 13
• 229920000159 gelatin Polymers 0.000 description 13
• 235000019322 gelatine Nutrition 0.000 description 13
• 235000011852 gelatine desserts Nutrition 0.000 description 13
• 230000001225 therapeutic effect Effects 0.000 description 13
• 102000007469 Actins Human genes 0.000 description 12
• 108010085238 Actins Proteins 0.000 description 12
• 230000000735 allogeneic effect Effects 0.000 description 12
• 239000000499 gel Substances 0.000 description 12
• 108020004999 messenger RNA Proteins 0.000 description 12
• 210000002966 serum Anatomy 0.000 description 12
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
• 241000283707 Capra Species 0.000 description 11
• 102000004190 Enzymes Human genes 0.000 description 11
• 108090000790 Enzymes Proteins 0.000 description 11
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 11
• 229930182555 Penicillin Natural products 0.000 description 11
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
• 230000001413 cellular effect Effects 0.000 description 11
• 230000006378 damage Effects 0.000 description 11
• 229940088598 enzyme Drugs 0.000 description 11
• 239000001301 oxygen Substances 0.000 description 11
• 229940049954 penicillin Drugs 0.000 description 11
• 229960005322 streptomycin Drugs 0.000 description 11
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
• 102000004127 Cytokines Human genes 0.000 description 10
• 108090000695 Cytokines Proteins 0.000 description 10
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
• 102000016610 Oxidized LDL Receptors Human genes 0.000 description 10
• 108010028191 Oxidized LDL Receptors Proteins 0.000 description 10
• 102100035071 Vimentin Human genes 0.000 description 10
• 108010065472 Vimentin Proteins 0.000 description 10
• 239000008103 glucose Substances 0.000 description 10
• 210000003205 muscle Anatomy 0.000 description 10
• 108090000765 processed proteins & peptides Proteins 0.000 description 10
• 239000000523 sample Substances 0.000 description 10
• 210000005048 vimentin Anatomy 0.000 description 10
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 9
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
• 230000004069 differentiation Effects 0.000 description 9
• 238000006073 displacement reaction Methods 0.000 description 9
• 102000004196 processed proteins & peptides Human genes 0.000 description 9
• 238000003753 real-time PCR Methods 0.000 description 9
• 238000011084 recovery Methods 0.000 description 9
• 238000012360 testing method Methods 0.000 description 9
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 8
• 108020004414 DNA Proteins 0.000 description 8
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 8
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 8
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 8
• 108010075704 HLA-A Antigens Proteins 0.000 description 8
• 102100025392 Isovaleryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 8
• 108090000631 Trypsin Proteins 0.000 description 8
• 102000004142 Trypsin Human genes 0.000 description 8
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 8
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 8
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 8
• 230000009286 beneficial effect Effects 0.000 description 8
• 239000003102 growth factor Substances 0.000 description 8
• 238000011534 incubation Methods 0.000 description 8
• 238000010186 staining Methods 0.000 description 8
• 239000012588 trypsin Substances 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 108060005980 Collagenase Proteins 0.000 description 7
• 102000029816 Collagenase Human genes 0.000 description 7
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 7
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 7
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 7
• 101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 7
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 7
• 102100026966 Thrombomodulin Human genes 0.000 description 7
• 239000006285 cell suspension Substances 0.000 description 7
• 239000003153 chemical reaction reagent Substances 0.000 description 7
• 229960002424 collagenase Drugs 0.000 description 7
• 230000003247 decreasing effect Effects 0.000 description 7
• 108010007093 dispase Proteins 0.000 description 7
• 238000002955 isolation Methods 0.000 description 7
• 108010071584 oxidized low density lipoprotein Proteins 0.000 description 7
• 239000008188 pellet Substances 0.000 description 7
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 7
• 229920003023 plastic Polymers 0.000 description 7
• 239000004033 plastic Substances 0.000 description 7
• 230000028327 secretion Effects 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 238000012384 transportation and delivery Methods 0.000 description 7
• 239000013598 vector Substances 0.000 description 7
• 108010047303 von Willebrand Factor Proteins 0.000 description 7
• 102100036537 von Willebrand factor Human genes 0.000 description 7
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• 102100036912 Desmin Human genes 0.000 description 6
• 108010044052 Desmin Proteins 0.000 description 6
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 6
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 6
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 6
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 6
• 108090001005 Interleukin-6 Proteins 0.000 description 6
• 102000004889 Interleukin-6 Human genes 0.000 description 6
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 6
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 6
• 229920000954 Polyglycolide Polymers 0.000 description 6
• 102000016611 Proteoglycans Human genes 0.000 description 6
• 108010067787 Proteoglycans Proteins 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• 238000003491 array Methods 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 238000005119 centrifugation Methods 0.000 description 6
• 210000001612 chondrocyte Anatomy 0.000 description 6
• 210000005045 desmin Anatomy 0.000 description 6
• 238000001514 detection method Methods 0.000 description 6
• 239000003937 drug carrier Substances 0.000 description 6
• 230000002500 effect on skin Effects 0.000 description 6
• 229940100601 interleukin-6 Drugs 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 108010067219 Aggrecans Proteins 0.000 description 5
• 102100034608 Angiopoietin-2 Human genes 0.000 description 5
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 5
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 5
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 5
• 102100036845 C-C motif chemokine 22 Human genes 0.000 description 5
• 102100021984 C-C motif chemokine 4-like Human genes 0.000 description 5
• 108010082169 Chemokine CCL17 Proteins 0.000 description 5
• 108010083701 Chemokine CCL22 Proteins 0.000 description 5
• 108010055165 Chemokine CCL4 Proteins 0.000 description 5
• 108010055166 Chemokine CCL5 Proteins 0.000 description 5
• 102000019034 Chemokines Human genes 0.000 description 5
• 108010012236 Chemokines Proteins 0.000 description 5
• 102000012422 Collagen Type I Human genes 0.000 description 5
• 108010022452 Collagen Type I Proteins 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 5
• 238000012286 ELISA Assay Methods 0.000 description 5
• 108010014258 Elastin Proteins 0.000 description 5
• 241000283074 Equus asinus Species 0.000 description 5
• 102100037362 Fibronectin Human genes 0.000 description 5
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 5
• 108010003272 Hyaluronate lyase Proteins 0.000 description 5
• 102000001974 Hyaluronidases Human genes 0.000 description 5
• 102100034980 ICOS ligand Human genes 0.000 description 5
• 101710093458 ICOS ligand Proteins 0.000 description 5
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 5
• 208000002193 Pain Diseases 0.000 description 5
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 5
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 5
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 5
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 5
• 108090000783 Renin Proteins 0.000 description 5
• 102100028255 Renin Human genes 0.000 description 5
• 210000001744 T-lymphocyte Anatomy 0.000 description 5
• 229920000615 alginic acid Polymers 0.000 description 5
• 235000010443 alginic acid Nutrition 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 230000003115 biocidal effect Effects 0.000 description 5
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 5
• 230000010261 cell growth Effects 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 238000012512 characterization method Methods 0.000 description 5
• 239000011248 coating agent Substances 0.000 description 5
• 238000000576 coating method Methods 0.000 description 5
• 239000003636 conditioned culture medium Substances 0.000 description 5
• 238000011156 evaluation Methods 0.000 description 5
• 238000002474 experimental method Methods 0.000 description 5
• 229940126864 fibroblast growth factor Drugs 0.000 description 5
• 239000006260 foam Substances 0.000 description 5
• 230000036541 health Effects 0.000 description 5
• 229960002773 hyaluronidase Drugs 0.000 description 5
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 5
• 238000002513 implantation Methods 0.000 description 5
• 238000011065 in-situ storage Methods 0.000 description 5
• 230000002757 inflammatory effect Effects 0.000 description 5
• 208000014674 injury Diseases 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 238000005259 measurement Methods 0.000 description 5
• 238000002493 microarray Methods 0.000 description 5
• 239000003068 molecular probe Substances 0.000 description 5
• 230000036407 pain Effects 0.000 description 5
• 210000002826 placenta Anatomy 0.000 description 5
• 210000002381 plasma Anatomy 0.000 description 5
• 210000004623 platelet-rich plasma Anatomy 0.000 description 5
• 229920001610 polycaprolactone Polymers 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 229960004295 valine Drugs 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 4
• 102100036601 Aggrecan core protein Human genes 0.000 description 4
• 108010048036 Angiopoietin-2 Proteins 0.000 description 4
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
• 102100034605 Atrial natriuretic peptide receptor 3 Human genes 0.000 description 4
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 4
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 4
• 108010008951 Chemokine CXCL12 Proteins 0.000 description 4
• 108010067306 Fibronectins Proteins 0.000 description 4
• 206010016654 Fibrosis Diseases 0.000 description 4
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 4
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 4
• 108010024164 HLA-G Antigens Proteins 0.000 description 4
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
• 101000924488 Homo sapiens Atrial natriuretic peptide receptor 3 Proteins 0.000 description 4
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 4
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 4
• 108010085895 Laminin Proteins 0.000 description 4
• 102000007547 Laminin Human genes 0.000 description 4
• 239000004677 Nylon Substances 0.000 description 4
• 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 4
• 101150040974 Set gene Proteins 0.000 description 4
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 4
• 102100021947 Survival motor neuron protein Human genes 0.000 description 4
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 4
• 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 4
• 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 4
• 230000001464 adherent effect Effects 0.000 description 4
• 229940072056 alginate Drugs 0.000 description 4
• 230000000202 analgesic effect Effects 0.000 description 4
• 230000001857 anti-mycotic effect Effects 0.000 description 4
• 210000000612 antigen-presenting cell Anatomy 0.000 description 4
• 239000002543 antimycotic Substances 0.000 description 4
• 230000000903 blocking effect Effects 0.000 description 4
• 229940112869 bone morphogenetic protein Drugs 0.000 description 4
• 239000001569 carbon dioxide Substances 0.000 description 4
• 229910002092 carbon dioxide Inorganic materials 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 229920001577 copolymer Polymers 0.000 description 4
• 238000012258 culturing Methods 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 230000004761 fibrosis Effects 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• 230000006870 function Effects 0.000 description 4
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 4
• 210000005260 human cell Anatomy 0.000 description 4
• 235000003642 hunger Nutrition 0.000 description 4
• 230000001900 immune effect Effects 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 230000006872 improvement Effects 0.000 description 4
• 238000011081 inoculation Methods 0.000 description 4
• 229920001778 nylon Polymers 0.000 description 4
• 229920001184 polypeptide Polymers 0.000 description 4
• 239000013641 positive control Substances 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 210000002460 smooth muscle Anatomy 0.000 description 4
• 230000037351 starvation Effects 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 238000002054 transplantation Methods 0.000 description 4
• 230000035899 viability Effects 0.000 description 4
• FQRHOOHLUYHMGG-BTJKTKAUSA-N 3-(2-acetylphenothiazin-10-yl)propyl-dimethylazanium;(z)-4-hydroxy-4-oxobut-2-enoate Chemical compound OC(=O)\C=C/C(O)=O.C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 FQRHOOHLUYHMGG-BTJKTKAUSA-N 0.000 description 3
• UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 102000004954 Biglycan Human genes 0.000 description 3
• 108090001138 Biglycan Proteins 0.000 description 3
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 3
• 108010014419 Chemokine CXCL1 Proteins 0.000 description 3
• 102000016950 Chemokine CXCL1 Human genes 0.000 description 3
• 102000050083 Class E Scavenger Receptors Human genes 0.000 description 3
• 102000007644 Colony-Stimulating Factors Human genes 0.000 description 3
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 3
• 208000034423 Delivery Diseases 0.000 description 3
• 102000016942 Elastin Human genes 0.000 description 3
• 102100033167 Elastin Human genes 0.000 description 3
• 102100023688 Eotaxin Human genes 0.000 description 3
• 101710139422 Eotaxin Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 108010073385 Fibrin Proteins 0.000 description 3
• 102000009123 Fibrin Human genes 0.000 description 3
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 3
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 3
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 3
• 102000015789 HLA-DP Antigens Human genes 0.000 description 3
• 108010010378 HLA-DP Antigens Proteins 0.000 description 3
• 108010062347 HLA-DQ Antigens Proteins 0.000 description 3
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 3
• 101000871708 Homo sapiens Proheparin-binding EGF-like growth factor Proteins 0.000 description 3
• 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 3
• 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 3
• 108010066327 Keratin-18 Proteins 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 229930040373 Paraformaldehyde Natural products 0.000 description 3
• 239000004698 Polyethylene Substances 0.000 description 3
• 108010000499 Thromboplastin Proteins 0.000 description 3
• 102100034195 Thrombopoietin Human genes 0.000 description 3
• 101710113649 Thyroid peroxidase Proteins 0.000 description 3
• 102100030859 Tissue factor Human genes 0.000 description 3
• 229920004890 Triton X-100 Polymers 0.000 description 3
• 239000013504 Triton X-100 Substances 0.000 description 3
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 3
• 108091009550 Vesicle-associated membrane protein 5 Proteins 0.000 description 3
• 208000027418 Wounds and injury Diseases 0.000 description 3
• 229960001946 acepromazine maleate Drugs 0.000 description 3
• 239000012190 activator Substances 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 210000000988 bone and bone Anatomy 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 3
• 229960001736 buprenorphine Drugs 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 238000013016 damping Methods 0.000 description 3
• 230000006735 deficit Effects 0.000 description 3
• 230000008021 deposition Effects 0.000 description 3
• 230000029087 digestion Effects 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 229920002549 elastin Polymers 0.000 description 3
• 210000001671 embryonic stem cell Anatomy 0.000 description 3
• 239000000835 fiber Substances 0.000 description 3
• 229950003499 fibrin Drugs 0.000 description 3
• 239000006481 glucose medium Substances 0.000 description 3
• 230000002519 immonomodulatory effect Effects 0.000 description 3
• 238000003364 immunohistochemistry Methods 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 229960004184 ketamine hydrochloride Drugs 0.000 description 3
• 210000003127 knee Anatomy 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 150000007523 nucleic acids Chemical class 0.000 description 3
• 235000015097 nutrients Nutrition 0.000 description 3
• 238000002966 oligonucleotide array Methods 0.000 description 3
• 229920002866 paraformaldehyde Polymers 0.000 description 3
• 230000035699 permeability Effects 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 238000011555 rabbit model Methods 0.000 description 3
• 238000010839 reverse transcription Methods 0.000 description 3
• 108091005418 scavenger receptor class E Proteins 0.000 description 3
• 230000009758 senescence Effects 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 239000012679 serum free medium Substances 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 210000000278 spinal cord Anatomy 0.000 description 3
• 230000003068 static effect Effects 0.000 description 3
• 230000008961 swelling Effects 0.000 description 3
• 239000003634 thrombocyte concentrate Substances 0.000 description 3
• 231100000331 toxic Toxicity 0.000 description 3
• 230000002588 toxic effect Effects 0.000 description 3
• 230000002103 transcriptional effect Effects 0.000 description 3
• 230000008733 trauma Effects 0.000 description 3
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 3
• 239000013603 viral vector Substances 0.000 description 3
• 229960001134 von willebrand factor Drugs 0.000 description 3
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
• 102100024394 Adipocyte enhancer-binding protein 1 Human genes 0.000 description 2
• 101710105604 Adipocyte enhancer-binding protein 1 Proteins 0.000 description 2
• 229920000936 Agarose Polymers 0.000 description 2
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 2
• 206010002091 Anaesthesia Diseases 0.000 description 2
• 108020005544 Antisense RNA Proteins 0.000 description 2
• 102100037140 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Human genes 0.000 description 2
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
• 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 2
• 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 2
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
• 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 2
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 2
• 102000001327 Chemokine CCL5 Human genes 0.000 description 2
• 108010079362 Core Binding Factor Alpha 3 Subunit Proteins 0.000 description 2
• 102100038497 Cytokine receptor-like factor 2 Human genes 0.000 description 2
• 102100031814 EGF-containing fibulin-like extracellular matrix protein 1 Human genes 0.000 description 2
• 101710176517 EGF-containing fibulin-like extracellular matrix protein 1 Proteins 0.000 description 2
• 206010015548 Euthanasia Diseases 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000014015 Growth Differentiation Factors Human genes 0.000 description 2
• 108010050777 Growth Differentiation Factors Proteins 0.000 description 2
• 102100039165 Heat shock protein beta-1 Human genes 0.000 description 2
• 101710100504 Heat shock protein beta-1 Proteins 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
• 102100037102 Homeobox protein MOX-2 Human genes 0.000 description 2
• 101000740545 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Proteins 0.000 description 2
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 2
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 2
• 101100220044 Homo sapiens CD34 gene Proteins 0.000 description 2
• 101000955037 Homo sapiens Homeobox protein MOX-2 Proteins 0.000 description 2
• 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 2
• 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 2
• 101000703741 Homo sapiens Short stature homeobox protein 2 Proteins 0.000 description 2
• 101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 description 2
• 101000830570 Homo sapiens Tumor necrosis factor alpha-induced protein 3 Proteins 0.000 description 2
• 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 2
• 108010074328 Interferon-gamma Proteins 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 208000008930 Low Back Pain Diseases 0.000 description 2
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
• 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
• ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 2
• 229930192392 Mitomycin Natural products 0.000 description 2
• 241000204031 Mycoplasma Species 0.000 description 2
• 238000011887 Necropsy Methods 0.000 description 2
• 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 2
• 102000004316 Oxidoreductases Human genes 0.000 description 2
• 108090000854 Oxidoreductases Proteins 0.000 description 2
• 241001631646 Papillomaviridae Species 0.000 description 2
• 108010026552 Proteome Proteins 0.000 description 2
• 238000002123 RNA extraction Methods 0.000 description 2
• 102100025369 Runt-related transcription factor 3 Human genes 0.000 description 2
• 102100031976 Short stature homeobox protein 2 Human genes 0.000 description 2
• 102000013275 Somatomedins Human genes 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 208000002220 Supravalvular aortic stenosis Diseases 0.000 description 2
• 208000002847 Surgical Wound Diseases 0.000 description 2
• 102000007000 Tenascin Human genes 0.000 description 2
• 108010008125 Tenascin Proteins 0.000 description 2
• 206010043276 Teratoma Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 description 2
• 102100034204 Transcription factor SOX-9 Human genes 0.000 description 2
• 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 2
• 102100031484 Vesicle-associated membrane protein 5 Human genes 0.000 description 2
• 108010028144 alpha-Glucosidases Proteins 0.000 description 2
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
• 229960003942 amphotericin b Drugs 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 230000037005 anaesthesia Effects 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 229940121363 anti-inflammatory agent Drugs 0.000 description 2
• 239000002260 anti-inflammatory agent Substances 0.000 description 2
• 230000003110 anti-inflammatory effect Effects 0.000 description 2
• 239000008365 aqueous carrier Substances 0.000 description 2
• 230000005784 autoimmunity Effects 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 210000004204 blood vessel Anatomy 0.000 description 2
• 239000012888 bovine serum Substances 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 239000007975 buffered saline Substances 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 235000011089 carbon dioxide Nutrition 0.000 description 2
• 210000000845 cartilage Anatomy 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 210000003855 cell nucleus Anatomy 0.000 description 2
• 239000002458 cell surface marker Substances 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 229940096422 collagen type i Drugs 0.000 description 2
• 239000003184 complementary RNA Substances 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 230000001186 cumulative effect Effects 0.000 description 2
• 230000003412 degenerative effect Effects 0.000 description 2
• 210000004177 elastic tissue Anatomy 0.000 description 2
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
• 210000004700 fetal blood Anatomy 0.000 description 2
• 230000001605 fetal effect Effects 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 229920002313 fluoropolymer Polymers 0.000 description 2
• 239000004811 fluoropolymer Substances 0.000 description 2
• 210000003953 foreskin Anatomy 0.000 description 2
• 238000004108 freeze drying Methods 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 238000011223 gene expression profiling Methods 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 230000009395 genetic defect Effects 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 238000003306 harvesting Methods 0.000 description 2
• 230000035876 healing Effects 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• 229960003160 hyaluronic acid Drugs 0.000 description 2
• 238000003365 immunocytochemistry Methods 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 230000036512 infertility Effects 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 108010046018 leukocyte inhibitory factor Proteins 0.000 description 2
• 239000012139 lysis buffer Substances 0.000 description 2
• 230000008774 maternal effect Effects 0.000 description 2
• 230000035800 maturation Effects 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 229960001929 meloxicam Drugs 0.000 description 2
• 210000005087 mononuclear cell Anatomy 0.000 description 2
• 210000002894 multi-fate stem cell Anatomy 0.000 description 2
• 238000011587 new zealand white rabbit Methods 0.000 description 2
• 230000001453 nonthrombogenic effect Effects 0.000 description 2
• 238000010899 nucleation Methods 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 102000039446 nucleic acids Human genes 0.000 description 2
• 108020004707 nucleic acids Proteins 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
• 210000005059 placental tissue Anatomy 0.000 description 2
• 210000001778 pluripotent stem cell Anatomy 0.000 description 2
• 229920000747 poly(lactic acid) Polymers 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 230000002980 postoperative effect Effects 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 238000004321 preservation Methods 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• 210000002097 psoas muscle Anatomy 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000003362 replicative effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 238000003118 sandwich ELISA Methods 0.000 description 2
• 231100000241 scar Toxicity 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 210000002536 stromal cell Anatomy 0.000 description 2
• 229920001059 synthetic polymer Polymers 0.000 description 2
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 229940104230 thymidine Drugs 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 229940072041 transforming growth factor beta 2 Drugs 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• RXSSENVGBNPHJJ-LBPRGKRZSA-N (2s)-2-(morpholine-4-carbonyloxy)-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)OC(=O)N1CCOCC1)C1=CC=CC=C1 RXSSENVGBNPHJJ-LBPRGKRZSA-N 0.000 description 1
• ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 1
• DZKLSFQAIYUHCL-UHFFFAOYSA-N 1,2-dihydroxy-2-(hydroxymethyl)icosan-3-one Chemical compound CCCCCCCCCCCCCCCCCC(=O)C(O)(CO)CO DZKLSFQAIYUHCL-UHFFFAOYSA-N 0.000 description 1
• 108020004463 18S ribosomal RNA Proteins 0.000 description 1
• WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• 102100027400 A disintegrin and metalloproteinase with thrombospondin motifs 4 Human genes 0.000 description 1
• 101710100373 A disintegrin and metalloproteinase with thrombospondin motifs 4 Proteins 0.000 description 1
• 102100033792 ALX homeobox protein 1 Human genes 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 102100027211 Albumin Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102100024090 Aldo-keto reductase family 1 member C3 Human genes 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100040743 Alpha-crystallin B chain Human genes 0.000 description 1
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
• 102100022987 Angiogenin Human genes 0.000 description 1
• 102100036817 Ankyrin-3 Human genes 0.000 description 1
• 108020004491 Antisense DNA Proteins 0.000 description 1
• 101100111164 Arabidopsis thaliana BAC2 gene Proteins 0.000 description 1
• XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
• XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
• 238000012935 Averaging Methods 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102100021961 Bis(5'-adenosyl)-triphosphatase ENPP4 Human genes 0.000 description 1
• 108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 1
• 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 1
• 102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 1
• 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
• 210000003771 C cell Anatomy 0.000 description 1
• 101100243951 Caenorhabditis elegans pie-1 gene Proteins 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 229920002101 Chitin Polymers 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 108010010786 Cholesterol 25-hydroxylase Proteins 0.000 description 1
• 229920001287 Chondroitin sulfate Polymers 0.000 description 1
• 102100032765 Chordin-like protein 1 Human genes 0.000 description 1
• 101710173231 Chordin-like protein 1 Proteins 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 102000004266 Collagen Type IV Human genes 0.000 description 1
• 108010042086 Collagen Type IV Proteins 0.000 description 1
• 102100024337 Collagen alpha-1(VIII) chain Human genes 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 102100026533 Cytochrome P450 1A2 Human genes 0.000 description 1
• 101710088434 Cytochrome c oxidase subunit 7A1, mitochondrial Proteins 0.000 description 1
• 102100025629 Cytochrome c oxidase subunit 7A1, mitochondrial Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 1
• 101710194728 Cytokine receptor-like factor 1 Proteins 0.000 description 1
• 101710194733 Cytokine receptor-like factor 2 Proteins 0.000 description 1
• 102100028530 Cytoplasmic dynein 1 intermediate chain 1 Human genes 0.000 description 1
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 102100032883 DNA-binding protein SATB2 Human genes 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• 108091027757 Deoxyribozyme Proteins 0.000 description 1
• 229920000045 Dermatan sulfate Polymers 0.000 description 1
• 102100028556 Disheveled-associated activator of morphogenesis 2 Human genes 0.000 description 1
• 101710093421 Disheveled-associated activator of morphogenesis 2 Proteins 0.000 description 1
• 102000010777 Dual Specificity Phosphatase 2 Human genes 0.000 description 1
• 108010038535 Dual Specificity Phosphatase 2 Proteins 0.000 description 1
• 102100021717 Early growth response protein 3 Human genes 0.000 description 1
• 102100039246 Elongator complex protein 1 Human genes 0.000 description 1
• 101710167754 Elongator complex protein 1 Proteins 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 102000002045 Endothelin Human genes 0.000 description 1
• 108050009340 Endothelin Proteins 0.000 description 1
• 108010055191 EphA3 Receptor Proteins 0.000 description 1
• 102100030324 Ephrin type-A receptor 3 Human genes 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 1
• 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 102100039676 Frizzled-7 Human genes 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 244000060234 Gmelina philippensis Species 0.000 description 1
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 101710204282 Growth/differentiation factor 5 Proteins 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 229920002971 Heparan sulfate Polymers 0.000 description 1
• 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
• 102000052396 Hephaestin Human genes 0.000 description 1
• 108700038053 Hephaestin Proteins 0.000 description 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
• 102100022373 Homeobox protein DLX-5 Human genes 0.000 description 1
• 102100029279 Homeobox protein SIX1 Human genes 0.000 description 1
• 102100027332 Homeobox protein SIX2 Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000779615 Homo sapiens ALX homeobox protein 1 Proteins 0.000 description 1
• 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 1
• 101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 1
• 101000924533 Homo sapiens Angiopoietin-2 Proteins 0.000 description 1
• 101000928342 Homo sapiens Ankyrin-3 Proteins 0.000 description 1
• 101000897056 Homo sapiens Bis(5'-adenosyl)-triphosphatase ENPP4 Proteins 0.000 description 1
• 101000909492 Homo sapiens Collagen alpha-1(VIII) chain Proteins 0.000 description 1
• 101000915295 Homo sapiens Cytoplasmic dynein 1 intermediate chain 1 Proteins 0.000 description 1
• 101000655236 Homo sapiens DNA-binding protein SATB2 Proteins 0.000 description 1
• 101000896450 Homo sapiens Early growth response protein 3 Proteins 0.000 description 1
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
• 101000885797 Homo sapiens Frizzled-7 Proteins 0.000 description 1
• 101001058904 Homo sapiens Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 101001066129 Homo sapiens Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 101000901627 Homo sapiens Homeobox protein DLX-5 Proteins 0.000 description 1
• 101000634171 Homo sapiens Homeobox protein SIX1 Proteins 0.000 description 1
• 101000651912 Homo sapiens Homeobox protein SIX2 Proteins 0.000 description 1
• 101001054732 Homo sapiens Inhibin beta A chain Proteins 0.000 description 1
• 101001015037 Homo sapiens Integrin beta-7 Proteins 0.000 description 1
• 101000997670 Homo sapiens Integrin beta-8 Proteins 0.000 description 1
• 101000976713 Homo sapiens Integrin beta-like protein 1 Proteins 0.000 description 1
• 101001003147 Homo sapiens Interleukin-11 receptor subunit alpha Proteins 0.000 description 1
• 101001026236 Homo sapiens Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 description 1
• 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 description 1
• 101000904196 Homo sapiens Pancreatic secretory granule membrane major glycoprotein GP2 Proteins 0.000 description 1
• 101000886179 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 3 Proteins 0.000 description 1
• 101000974737 Homo sapiens Potassium channel subfamily K member 15 Proteins 0.000 description 1
• 101000612134 Homo sapiens Procollagen C-endopeptidase enhancer 1 Proteins 0.000 description 1
• 101000652172 Homo sapiens Protein Smaug homolog 1 Proteins 0.000 description 1
• 101000861454 Homo sapiens Protein c-Fos Proteins 0.000 description 1
• 101000736906 Homo sapiens Protein prune homolog 2 Proteins 0.000 description 1
• 101000615238 Homo sapiens Proto-oncogene DBL Proteins 0.000 description 1
• 101000880310 Homo sapiens SH3 and cysteine-rich domain-containing protein Proteins 0.000 description 1
• 101000727795 Homo sapiens Solute carrier family 35 member F5 Proteins 0.000 description 1
• 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 description 1
• 101000648552 Homo sapiens Sushi domain-containing protein 5 Proteins 0.000 description 1
• 101000626125 Homo sapiens Tetranectin Proteins 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
• 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
• 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
• 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
• 108091058560 IL8 Proteins 0.000 description 1
• 102100027004 Inhibin beta A chain Human genes 0.000 description 1
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
• 102100033016 Integrin beta-7 Human genes 0.000 description 1
• 102100033336 Integrin beta-8 Human genes 0.000 description 1
• 102100023481 Integrin beta-like protein 1 Human genes 0.000 description 1
• 102100020787 Interleukin-11 receptor subunit alpha Human genes 0.000 description 1
• 102100036679 Interleukin-26 Human genes 0.000 description 1
• 101710181612 Interleukin-26 Proteins 0.000 description 1
• 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 description 1
• 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
• 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
• 102100023529 Iroquois-class homeodomain protein IRX-5 Human genes 0.000 description 1
• 101710136127 Iroquois-class homeodomain protein IRX-5 Proteins 0.000 description 1
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
• 102100033529 Keratin-associated protein 1-1 Human genes 0.000 description 1
• 101710183636 Keratin-associated protein 1-1 Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
• 108010052014 Liberase Proteins 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
• 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
• 101710091439 Major capsid protein 1 Proteins 0.000 description 1
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
• 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
• 108010093175 Member 2 Group A Nuclear Receptor Subfamily 4 Proteins 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000005741 Metalloproteases Human genes 0.000 description 1
• 108010006035 Metalloproteases Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 102000019305 Microtubule associated protein 1A Human genes 0.000 description 1
• 108050006673 Microtubule associated protein 1A Proteins 0.000 description 1
• 241000751119 Mila <angiosperm> Species 0.000 description 1
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
• 102000002452 NPR3 Human genes 0.000 description 1
• 101150066297 NPR3 gene Proteins 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 102000035092 Neutral proteases Human genes 0.000 description 1
• 108091005507 Neutral proteases Proteins 0.000 description 1
• 206010067482 No adverse event Diseases 0.000 description 1
• 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 description 1
• 102100037589 OX-2 membrane glycoprotein Human genes 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 208000008558 Osteophyte Diseases 0.000 description 1
• 229920002201 Oxidized cellulose Polymers 0.000 description 1
• 102100029181 PDZ and LIM domain protein 5 Human genes 0.000 description 1
• 102100024019 Pancreatic secretory granule membrane major glycoprotein GP2 Human genes 0.000 description 1
• 241000051107 Paraechinus aethiopicus Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 101000931422 Photobacterium phosphoreum Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 102100039685 Polypeptide N-acetylgalactosaminyltransferase 3 Human genes 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 102100022797 Potassium channel subfamily K member 15 Human genes 0.000 description 1
• TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
• 101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
• 102100041026 Procollagen C-endopeptidase enhancer 1 Human genes 0.000 description 1
• 102100038931 Proenkephalin-A Human genes 0.000 description 1
• 108010065942 Prostaglandin-F synthase Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 102100030591 Protein Smaug homolog 1 Human genes 0.000 description 1
• 102100027584 Protein c-Fos Human genes 0.000 description 1
• 102100036040 Protein prune homolog 2 Human genes 0.000 description 1
• 108700020978 Proto-Oncogene Proteins 0.000 description 1
• 102000052575 Proto-Oncogene Human genes 0.000 description 1
• 102100021384 Proto-oncogene DBL Human genes 0.000 description 1
• 102000005917 R-SNARE Proteins Human genes 0.000 description 1
• 108010005730 R-SNARE Proteins Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 108090000244 Rat Proteins Proteins 0.000 description 1
• 229940123934 Reductase inhibitor Drugs 0.000 description 1
• 108010081750 Reticulin Proteins 0.000 description 1
• 235000004789 Rosa xanthina Nutrition 0.000 description 1
• 241000109329 Rosa xanthina Species 0.000 description 1
• 108091007110 SCF2 complex Proteins 0.000 description 1
• 102100037646 SH3 and cysteine-rich domain-containing protein Human genes 0.000 description 1
• RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
• 101000752546 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Transaminated amino acid decarboxylase Proteins 0.000 description 1
• 206010039897 Sedation Diseases 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 102100030112 Solute carrier family 35 member F5 Human genes 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 102100028859 Sushi domain-containing protein 5 Human genes 0.000 description 1
• 229920006362 Teflon® Polymers 0.000 description 1
• 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
• 102100024554 Tetranectin Human genes 0.000 description 1
• 102000036693 Thrombopoietin Human genes 0.000 description 1
• 108010041111 Thrombopoietin Proteins 0.000 description 1
• 102000033162 Vesicle-associated membrane protein 5 Human genes 0.000 description 1
• 229930003268 Vitamin C Natural products 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 108010031318 Vitronectin Proteins 0.000 description 1
• 102100035140 Vitronectin Human genes 0.000 description 1
• 206010049644 Williams syndrome Diseases 0.000 description 1
• 201000001305 Williams-Beuren syndrome Diseases 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 102100024669 Zinc finger protein 41 Human genes 0.000 description 1
• 101710160539 Zinc finger protein 41 Proteins 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 210000000577 adipose tissue Anatomy 0.000 description 1
• 239000012574 advanced DMEM Substances 0.000 description 1
• 238000012382 advanced drug delivery Methods 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 230000002009 allergenic effect Effects 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 238000000540 analysis of variance Methods 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 239000002870 angiogenesis inducing agent Substances 0.000 description 1
• 230000002491 angiogenic effect Effects 0.000 description 1
• 108010072788 angiogenin Proteins 0.000 description 1
• 230000002424 anti-apoptotic effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000003146 anticoagulant agent Substances 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 239000003816 antisense DNA Substances 0.000 description 1
• 229960004676 antithrombotic agent Drugs 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 108010045569 atelocollagen Proteins 0.000 description 1
• 229960005370 atorvastatin Drugs 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 239000007640 basal medium Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 239000012867 bioactive agent Substances 0.000 description 1
• 238000006065 biodegradation reaction Methods 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000000740 bleeding effect Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 238000009960 carding Methods 0.000 description 1
• 230000001925 catabolic effect Effects 0.000 description 1
• 229940105657 catalase Drugs 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 230000033077 cellular process Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 229960005110 cerivastatin Drugs 0.000 description 1
• SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
• KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 230000035602 clotting Effects 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000002788 crimping Methods 0.000 description 1
• 229920006037 cross link polymer Polymers 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 108010057085 cytokine receptors Proteins 0.000 description 1
• 102000003675 cytokine receptors Human genes 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 230000032798 delamination Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000009795 derivation Methods 0.000 description 1
• 229940051593 dermatan sulfate Drugs 0.000 description 1
• AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 235000015872 dietary supplement Nutrition 0.000 description 1
• 230000003467 diminishing effect Effects 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 201000011025 embryonal testis carcinoma Diseases 0.000 description 1
• 230000002996 emotional effect Effects 0.000 description 1
• 230000003511 endothelial effect Effects 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 239000003822 epoxy resin Substances 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 201000010934 exostosis Diseases 0.000 description 1
• 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
• 238000001125 extrusion Methods 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 210000000604 fetal stem cell Anatomy 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 239000003527 fibrinolytic agent Substances 0.000 description 1
• 239000000706 filtrate Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000009093 first-line therapy Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
• 229960003765 fluvastatin Drugs 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 238000001879 gelation Methods 0.000 description 1
• 238000003633 gene expression assay Methods 0.000 description 1
• 238000003197 gene knockdown Methods 0.000 description 1
• 238000002695 general anesthesia Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 102000055297 human CXCL1 Human genes 0.000 description 1
• 102000047486 human GAPDH Human genes 0.000 description 1
• 229940106780 human fibrinogen Drugs 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 229920001477 hydrophilic polymer Polymers 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 238000013394 immunophenotyping Methods 0.000 description 1
• 238000012744 immunostaining Methods 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000000415 inactivating effect Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000030214 innervation Effects 0.000 description 1
• 239000002054 inoculum Substances 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 229960002725 isoflurane Drugs 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 208000028755 loss of height Diseases 0.000 description 1
• 229960004844 lovastatin Drugs 0.000 description 1
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
• 210000004705 lumbosacral region Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000007257 malfunction Effects 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000003340 mental effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• RFJIYBACSXLSEQ-UHFFFAOYSA-N monostearoylglycerol Natural products CCCCCCCCCCCCCCCCCOCC(O)CO RFJIYBACSXLSEQ-UHFFFAOYSA-N 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 230000000510 mucolytic effect Effects 0.000 description 1
• 230000003533 narcotic effect Effects 0.000 description 1
• 229920005615 natural polymer Polymers 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 238000010984 neurological examination Methods 0.000 description 1
• 230000000324 neuroprotective effect Effects 0.000 description 1
• 230000000508 neurotrophic effect Effects 0.000 description 1
• 239000004745 nonwoven fabric Substances 0.000 description 1
• 229960000988 nystatin Drugs 0.000 description 1
• VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 238000001543 one-way ANOVA Methods 0.000 description 1
• 230000000399 orthopedic effect Effects 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 210000002997 osteoclast Anatomy 0.000 description 1
• 210000004409 osteocyte Anatomy 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 229940107304 oxidized cellulose Drugs 0.000 description 1
• 238000002559 palpation Methods 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 229940056360 penicillin g Drugs 0.000 description 1
• 229960001412 pentobarbital Drugs 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
• 108010000685 platelet-derived growth factor AB Proteins 0.000 description 1
• 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
• 229920000058 polyacrylate Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920000647 polyepoxide Polymers 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 108010055896 polyornithine Proteins 0.000 description 1
• 229920002714 polyornithine Polymers 0.000 description 1
• 229920001451 polypropylene glycol Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920003226 polyurethane urea Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 238000010149 post-hoc-test Methods 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 229960002965 pravastatin Drugs 0.000 description 1
• TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 108010041071 proenkephalin Proteins 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 238000003498 protein array Methods 0.000 description 1
• 238000005086 pumping Methods 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 239000011535 reaction buffer Substances 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000000979 retarding effect Effects 0.000 description 1
• 238000012340 reverse transcriptase PCR Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 229920002477 rna polymer Polymers 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 230000036280 sedation Effects 0.000 description 1
• 230000011218 segmentation Effects 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229960002855 simvastatin Drugs 0.000 description 1
• RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 210000001626 skin fibroblast Anatomy 0.000 description 1
• 239000004055 small Interfering RNA Substances 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 108010048090 soybean lectin Proteins 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 229960002385 streptomycin sulfate Drugs 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 238000011477 surgical intervention Methods 0.000 description 1
• 210000002504 synaptic vesicle Anatomy 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 108010057210 telomerase RNA Proteins 0.000 description 1
• 102000055501 telomere Human genes 0.000 description 1
• 108091035539 telomere Proteins 0.000 description 1
• 210000003411 telomere Anatomy 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 206010062123 testicular embryonal carcinoma Diseases 0.000 description 1
• 239000004753 textile Substances 0.000 description 1
• 238000010257 thawing Methods 0.000 description 1
• 229960003766 thrombin (human) Drugs 0.000 description 1
• 230000036962 time dependent Effects 0.000 description 1
• 230000008467 tissue growth Effects 0.000 description 1
• 230000002110 toxicologic effect Effects 0.000 description 1
• 231100000027 toxicology Toxicity 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 238000002627 tracheal intubation Methods 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 239000003656 tris buffered saline Substances 0.000 description 1
• 229960001814 trypan blue Drugs 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 244000052613 viral pathogen Species 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 235000019154 vitamin C Nutrition 0.000 description 1
• 239000011718 vitamin C Substances 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 230000036642 wellbeing Effects 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
• 229960001600 xylazine Drugs 0.000 description 1